This website or its third party tools use cookies, which are necessary to its functioning and required to achieve the purposes illustrated in the cookie policy. If you want to know more or withdraw your consent to all or some of the cookies, please refer to the cookie policy. By closing this banner you agree to the use of cookies.

Technical Statistical Marketing

Show preferences Accept all

Tuesday, March 1st, 2016 - General News

CONTINUUS awarded SBIR Phase II grant from the NSF

CONTINUUS Pharmaceuticals was awarded a Phase II SBIR grant from the National Science Foundation to further develop its breakthrough ICM technology. This Phase II grant consists of $750,000 over a two year period, with the opportunity for additional matching funds to facilitate commercial partnerships.

Share news

Request Information

Phone: (781) 281-0115 Main Office

Email: [email protected]